More than 50 years of landmark results

Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.

Solutions for Complex Cases

Antitrust

Commodities

Data Privacy

Health Care

Securities

Professional Recommendations

“[Lowey Dannenberg] has considerable experience in litigating ‘some of the largest class actions throughout the country.’ . . . . The quality of their representation is also evidenced by the fact that Class Members, including sophisticated institutional investors, have not objected to the Settlement. The Court has no reason to doubt the quality of their representation.”

Hon. Gregory H. Woods, July 7, 2022 Fairness HearingTranscript, at p. 24 in In re JPMorgan Precious Metals Spoofing Litigation 18 Civ. 10356 (S.D.N.Y.)

“The court appreciates class counsel’s taking on these challenges and class counsel’s able navigation of these hard problems, in developing the case on behalf of the putative class, and in bringing contentious settlement negotiations to a successful outcome.

I might add too that the settlement was not only successful. Compared with many analogous cases, it was also prompt, a fact that brings obvious advantages to the class.”

Hon. Paul Engelmayer, May 31, 2022 Fairness Hearing Transcript, at p. 30 in In re JPMorgan Treasury Spoofing Litigation, 20 Civ. 3515 (S.D.N.Y.)

Recent Cases

Amgen

Health Care, Healthcare

By Gerald Lawrence

On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]

Read More

Adobe Class Action

Data Breach and Privacy, Existing Cases

By Amanda Fiorilla

On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining […]

Read More

UCSF Class Action

Data Breach and Privacy, Existing Cases

By Christian Levis

In Doe v. The Regents of the University of California, No. 3:23-cv-00598 (N.D. Cal.), Lowey Dannenberg represents a class of individuals who used the University of California San Francisco Medical […]

Read More

News

Blog

23andMe’s Business Strategy Highlights the Need for More Data Privacy Laws

Nov 18, 2021

23andMe rose to success by selling at home DNA tests ultimately purchased by more than 11 million individuals. By some estimates 1 in 5 Americans have handed over their DNA to 23andMe or companies like it.[1] But for many of these individuals, while they may believe that 23andMe is only using...

Have a Case You Think We Can Help With?

Get Our Newsletter